Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials

Table 2 Summary of medication adherence measures in included studies

Source	Method of measuring adherence	Medication involved	Outcome
Calvert [14], 2012	Patient self-report and prescription records assessment	Aspirin, β-blocker, and lipid-lowering drug	No significant difference in self-reported adherence
Calvert [14], 2012	Patient self-report and prescription records assessment	Aspirin, β-blocker, and lipid-lowering drug	Better adherence to β-blocker in prescription assessed adherence in intervention than in control (P = 0.03)
The MEDMAN study [15], 2007	Patient self-report	Aspirin, lipid-lowering drug, β-blocker, and ACE inhibitor	No significant difference
Faulkner [16], 2000	Pill counts at 6 and 12 weeks and prescription records assessment at 1 and 2 years	Lipid-lowering drug	No significant difference at 6 or 12 weeks
Faulkner [16], 2000		Lipid-lowering drug	Medication compliance was significantly higher in intervention than in control (P < 0.05)
Olson [17], 2009	Prescription records assessment	Lipid-lowering drug	No significant difference
Straka [18], 2005	Prescription records assessment	Lipid-lowering drug	Medication compliance was higher in intervention than in control (78% versus 44.1%)

ISSN: 1472-6963